Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation

Table 3 Multivariate analysis of factors affecting distant metastasis

	Odds Ratio	95 % CI	p-value
Age	1.046	0.999–1.095	0.054
Gender	0.688	0.197–2.401	0.557
Tumor size	1.04	0.999–1.095	0.083
Histologic type	0.816	0.182–3.66	0.790
Pathologic T stage	0.142	0.005–4.016	0.252
Extrathyroidal extension	19.535	0.618–617.017	0.091
Pathologic N stage	0.922	0.141–6.053	0.933
Lateral lymph node metastasis	11.159	1.902–65.461	0.008
TERT promoter mutation	155.298	3.362–999.990	0.009
BRAF V600E mutation	0.083	0.021–0.327	<0.001

ISSN: 1746-1596